Kesler Norman & Wride LLC Makes New $563,000 Investment in iShares Biotechnology ETF $IBB

Kesler Norman & Wride LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,335 shares of the financial services provider’s stock, valued at approximately $563,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Allspring Global Investments Holdings LLC lifted its holdings in iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after purchasing an additional 46,806 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $1,907,000. Central Pacific Bank Trust Division raised its position in shares of iShares Biotechnology ETF by 296,500.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after purchasing an additional 14,825 shares during the last quarter. Tudor Investment Corp ET AL acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth about $931,000. Finally, WorthPointe LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter valued at about $1,424,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 2.0%

IBB stock opened at $167.50 on Thursday. iShares Biotechnology ETF has a 12-month low of $123.61 and a 12-month high of $179.64. The business’s 50-day moving average is $169.70 and its 200 day moving average is $170.51.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.